Published in J Biol Chem on July 14, 2014
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLoS One (2015) 0.84
Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA). Mol Biotechnol (2015) 0.81
An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog (2015) 0.81
Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases. J Immunol Res (2015) 0.80
Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis. Clin Vaccine Immunol (2016) 0.77
Draft genomes of Shigella strains used by the STOPENTERICS consortium. Gut Pathog (2015) 0.75
Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response. Infect Immun (2016) 0.75
Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations. Int J Med Microbiol (2015) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. J Bacteriol (1958) 9.57
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature (2009) 8.99
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res (2000) 4.00
Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res (1990) 3.74
Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol (2002) 3.56
Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev (2010) 3.27
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide. J Clin Invest (1996) 2.94
Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res (2006) 2.24
Protection of monkeys against experimental shigellosis with a living attenuated oral polyvalent dysentery vaccine. J Bacteriol (1966) 2.23
Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem (1997) 2.17
Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun (2001) 2.16
The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol (2007) 2.16
Shigella isolates from the global enteric multicenter study inform vaccine development. Clin Infect Dis (2014) 2.15
Structure and genetics of Shigella O antigens. FEMS Microbiol Rev (2008) 2.11
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol (2007) 2.11
Function of the htrB high temperature requirement gene of Escherichia coli in the acylation of lipid A: HtrB catalyzed incorporation of laurate. J Biol Chem (1996) 2.02
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
Effect of cold shock on lipid A biosynthesis in Escherichia coli. Induction At 12 degrees C of an acyltransferase specific for palmitoleoyl-acyl carrier protein. J Biol Chem (1999) 1.75
Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerg Infect Dis (2010) 1.72
Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Proc Natl Acad Sci U S A (2012) 1.63
A triple mutant of Escherichia coli lacking secondary acyl chains on lipid A. J Biol Chem (2002) 1.60
Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium. J Immunol (2002) 1.59
Circulating cytokines as mediators of fever. Clin Infect Dis (2000) 1.51
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88. Proc Natl Acad Sci U S A (2011) 1.44
Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem (2000) 1.33
Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic Escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics (2007) 1.30
Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2. Clin Vaccine Immunol (2008) 1.22
Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin. J Infect Dis (2008) 1.19
An Escherichia coli mutant lacking the cold shock-induced palmitoleoyltransferase of lipid A biosynthesis: absence of unsaturated acyl chains and antibiotic hypersensitivity at 12 degrees C. J Biol Chem (2002) 1.17
High yield production process for Shigella outer membrane particles. PLoS One (2012) 1.12
The complete sequence and analysis of the large virulence plasmid pSS of Shigella sonnei. Plasmid (2005) 1.03
A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA). Vaccine (2014) 0.97
A scalable method for O-antigen purification applied to various Salmonella serovars. Anal Biochem (2012) 0.97
Lipopolysaccharide with an altered O-antigen produced in Escherichia coli K-12 harbouring mutated, cloned Shigella flexneri rfb genes. Mol Microbiol (1995) 0.94
Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant. J Microbiol Biotechnol (2009) 0.93
Minor modifications to the phosphate groups and the C3' acyl chain length of lipid A in two Bordetella pertussis strains, BP338 and 18-323, independently affect Toll-like receptor 4 protein activation. J Biol Chem (2013) 0.92
Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants. Clin Vaccine Immunol (2009) 0.89
Causative species and serotypes of shigellosis in mainland China: systematic review and meta-analysis. PLoS One (2012) 0.89
Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants. Infect Immun (2009) 0.88
Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production. Innate Immun (2010) 0.85
Site-specific acylation changes in the lipid A of Escherichia coli lpxL mutants grown at high temperatures. Innate Immun (2013) 0.79